Skip to content

Clinical trials

Observational Carcinoma trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma Phase: Observational Country / region: China Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20121
20162
20171
20183
20192
20201
20211
20222
20231
20241
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status7
Completed6
Recruiting5
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Peking University People's Hospital7
Jinling Hospital, China2
Bayer1
Creative Biosciences (Guangzhou) Co., Ltd.1
Eye & ENT Hospital of Fudan University1
First Hospital of Shijiazhuang City1
Fudan University1
Qilu Hospital of Shandong University1
Shanghai Chest Hospital1
West China Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma19
Carcinoma, Non-Small-Cell Lung9
Lung Neoplasms9
Carcinoma, Renal Cell3
Adenocarcinoma2
Disease2
Kidney Neoplasms2
Bronchitis1
Bronchitis, Chronic1
Carcinoma, Adenoid Cystic1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.